US 10233209
Inhibitors of the farnesoid x receptor and uses in medicine
granted A61PA61P1/16A61P3/04
Quick answer
US patent 10233209 (Inhibitors of the farnesoid x receptor and uses in medicine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/16, A61P3/04, A61P3/06, A61P3/10